• Published On : Jan-2018 |
  • Pages : 159 Pages |
  • Format :

1. Executive Summary
   1.1. Market Overview
   1.2. Market Analysis
   1.3. PMR Analysis and Recommendations
   1.4. Wheel of Fortune

2. Market Introduction
   2.1. Market Definition
   2.2. Market Taxonomy

3. Oligonucleotide Synthesis Market View Point
   3.1. Macro-Economic Factors
   3.2. Opportunity Analysis

4. North America Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025
   4.1. Introduction
   4.2. Regional Market Dynamics
        4.2.1. Drivers
        4.2.2. Restraints
        4.2.3. Trends
   4.3. Historical Market Size (US$ Mn) By Country, 2012-2016
        4.3.1. U.S.
        4.3.2. Canada
   4.4. Market Size (US$ Mn) Forecast By Country, 2017-2025
        4.4.1. U.S.
        4.4.2. Canada
   4.5. Historical Market Size (US$ Mn) By Service Type, 2012-2016
        4.5.1. Universal Oligonucleotide Synthesis 
        4.5.2. Custom Oligonucleotide Synthesis
   4.6. Market Size (US$ Mn) Forecast By Service Type, 2017-2025
        4.6.1. Universal Oligonucleotide Synthesis 
        4.6.2. Custom Oligonucleotide Synthesis
   4.7. Historical Market Size (US$ Mn) By Application, 2012-2016
        4.7.1. Research & Development 
        4.7.2. Clinical & Commercial  
   4.8. Market Size (US$ Mn) Forecast By Application, 2017-2025
        4.8.1. Research & Development 
        4.8.2. Clinical & Commercial  
   4.9. Historical Market Size (US$ Mn) By End Users, 2012-2016
        4.9.1. Biopharmaceutical Companies
        4.9.2. Academic & Research Institutes     
        4.9.3. Contract Research Organizations
   4.10. Market Size (US$ Mn) Forecast By End Users, 2017-2025
        4.10.1. Biopharmaceutical Companies
        4.10.2. Academic & Research Institutes     
        4.10.3. Contract Research Organizations
   4.11. Market Attractiveness Analysis
        4.11.1. By Country
        4.11.2. By Service Type
        4.11.3. By Application
        4.11.4. By End Users
   4.12. Key Representative Market Participants
   4.13. Market Presence (Intensity Map)

5. Latin America Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025
   5.1. Introduction
   5.2. Regional Market Dynamics
        5.2.1. Drivers
        5.2.2. Restraints
        5.2.3. Trends
   5.3. Historical Market Size (US$ Mn) By Country, 2012-2016
        5.3.1. Brazil
        5.3.2. Mexico
        5.3.3. Rest of Latin America
   5.4. Market Size (US$ Mn) Forecast By Country, 2017-2025
        5.4.1. Brazil
        5.4.2. Mexico
        5.4.3. Rest of Latin America
   5.5. Historical Market Size (US$ Mn) By Service Type, 2012-2016
        5.5.1. Universal Oligonucleotide Synthesis 
        5.5.2. Custom Oligonucleotide Synthesis
   5.6. Market Size (US$ Mn) Forecast By Service Type, 2017-2025
        5.6.1. Universal Oligonucleotide Synthesis 
        5.6.2. Custom Oligonucleotide Synthesis
   5.7. Historical Market Size (US$ Mn) By Application, 2012-2016
        5.7.1. Research & Development 
        5.7.2. Clinical & Commercial  
   5.8. Market Size (US$ Mn) Forecast By Application, 2017-2025
        5.8.1. Research & Development 
        5.8.2. Clinical & Commercial  
   5.9. Historical Market Size (US$ Mn) By End Users, 2012-2016
        5.9.1. Biopharmaceutical Companies
        5.9.2. Academic & Research Institutes     
        5.9.3. Contract Research Organizations
   5.10. Market Size (US$ Mn) Forecast By End Users, 2017-2025
        5.10.1. Biopharmaceutical Companies
        5.10.2. Academic & Research Institutes     
        5.10.3. Contract Research Organizations
   5.11. Market Attractiveness Analysis
        5.11.1. By Country
        5.11.2. By Service Type
        5.11.3. By Application
        5.11.4. By End Users
   5.12. Key Representative Market Participants
   5.13. Market Presence (Intensity Map)

6. Europe Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025
   6.1. Introduction
   6.2. Regional Market Dynamics
        6.2.1. Drivers
        6.2.2. Restraints
        6.2.3. Trends
   6.3. Historical Market Size (US$ Mn) By Country, 2012-2016
        6.3.1. Germany
        6.3.2. U.K.
        6.3.3. France
        6.3.4. Italy
        6.3.5. Spain
        6.3.6. Poland
        6.3.7. Russia
        6.3.8. Rest of Europe
   6.4. Market Size (US$ Mn) Forecast By Country, 2017-2025
        6.4.1. Germany
        6.4.2. U.K.
        6.4.3. France
        6.4.4. Italy
        6.4.5. Spain
        6.4.6. Russia
        6.4.7. Rest of Europe
   6.5. Historical Market Size (US$ Mn) By Service Type, 2012-2016
        6.5.1. Universal Oligonucleotide Synthesis 
        6.5.2. Custom Oligonucleotide Synthesis
   6.6. Market Size (US$ Mn) Forecast By Service Type, 2017-2025
        6.6.1. Universal Oligonucleotide Synthesis 
        6.6.2. Custom Oligonucleotide Synthesis
   6.7. Historical Market Size (US$ Mn) By Application, 2012-2016
        6.7.1. Research & Development 
        6.7.2. Clinical & Commercial  
   6.8. Market Size (US$ Mn) Forecast By Application, 2017-2025
        6.8.1. Research & Development 
        6.8.2. Clinical & Commercial  
   6.9. Historical Market Size (US$ Mn) By End Users, 2012-2016
        6.9.1. Biopharmaceutical Companies
        6.9.2. Academic & Research Institutes     
        6.9.3. Contract Research Organizations
   6.10. Market Size (US$ Mn) Forecast By End Users, 2017-2025
        6.10.1. Biopharmaceutical Companies
        6.10.2. Academic & Research Institutes     
        6.10.3. Contract Research Organizations
   6.11. Market Attractiveness Analysis
        6.11.1. By Country
        6.11.2. By Service Type
        6.11.3. By Application
        6.11.4. By End Users
   6.12. Key Representative Market Participants
   6.13. Market Presence (Intensity Map)

7. Asia Pacific (APAC) Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025
   7.1. Introduction
   7.2. Regional Market Dynamics
        7.2.1. Drivers
        7.2.2. Restraints
        7.2.3. Trends
   7.3. Historical Market Size (US$ Mn) By Country, 2012-2016
        7.3.1. China
        7.3.2. India
        7.3.3. Japan
        7.3.4. Australia and New Zealand
        7.3.5. Rest of APAC
   7.4. Market Size (US$ Mn) Forecast By Country, 2017-2025
        7.4.1. China
        7.4.2. India
        7.4.3. Japan
        7.4.4. Australia and New Zealand
        7.4.5. Rest of APAC
   7.5. Historical Market Size (US$ Mn) By Service Type, 2012-2016
        7.5.1. Universal Oligonucleotide Synthesis 
        7.5.2. Custom Oligonucleotide Synthesis
   7.6. Market Size (US$ Mn) Forecast By Service Type, 2017-2025
        7.6.1. Universal Oligonucleotide Synthesis 
        7.6.2. Custom Oligonucleotide Synthesis
   7.7. Historical Market Size (US$ Mn) By Application, 2012-2016
        7.7.1. Research & Development 
        7.7.2. Clinical & Commercial  
   7.8. Market Size (US$ Mn) Forecast By Application, 2017-2025
        7.8.1. Research & Development 
        7.8.2. Clinical & Commercial  
   7.9. Historical Market Size (US$ Mn) By End Users, 2012-2016
        7.9.1. Biopharmaceutical Companies
        7.9.2. Academic & Research Institutes     
        7.9.3. Contract Research Organizations
   7.10. Market Size (US$ Mn) Forecast By End Users, 2017-2025
        7.10.1. Biopharmaceutical Companies
        7.10.2. Academic & Research Institutes     
        7.10.3. Contract Research Organizations
   7.11. Market Attractiveness Analysis
        7.11.1. By Country
        7.11.2. By Service Type
        7.11.3. By Application
        7.11.4. By End Users
   7.12. Key Representative Market Participants
   7.13. Market Presence (Intensity Map)

8. Middle East and Africa (MEA) Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025
   8.1. Introduction
   8.2. Regional Market Dynamics
        8.2.1. Drivers
        8.2.2. Restraints
        8.2.3. Trends
   8.3. Historical Market Size (US$ Mn) By Country, 2012-2016
        8.3.1. GCC Countries
        8.3.2. South Africa
        8.3.3. Rest of MEA
   8.4. Market Size (US$ Mn) Forecast By Country, 2017-2025
        8.4.1. GCC Countries
        8.4.2. South Africa
        8.4.3. Rest of MEA
   8.5. Historical Market Size (US$ Mn) By Service Type, 2012-2016
        8.5.1. Universal Oligonucleotide Synthesis 
        8.5.2. Custom Oligonucleotide Synthesis
   8.6. Market Size (US$ Mn) Forecast By Service Type, 2017-2025
        8.6.1. Universal Oligonucleotide Synthesis 
        8.6.2. Custom Oligonucleotide Synthesis
   8.7. Historical Market Size (US$ Mn) By Application, 2012-2016
        8.7.1. Research & Development 
        8.7.2. Clinical & Commercial  
   8.8. Market Size (US$ Mn) Forecast By Application, 2017-2025
        8.8.1. Research & Development 
        8.8.2. Clinical & Commercial  
   8.9. Historical Market Size (US$ Mn) By End Users, 2012-2016
        8.9.1. Biopharmaceutical Companies
        8.9.2. Academic & Research Institutes     
        8.9.3. Contract Research Organizations
   8.10. Market Size (US$ Mn) Forecast By End Users, 2017-2025
        8.10.1. Biopharmaceutical Companies
        8.10.2. Academic & Research Institutes     
        8.10.3. Contract Research Organizations
   8.11. Market Attractiveness Analysis
        8.11.1. By Country
        8.11.2. By Service Type
        8.11.3. By Application
        8.11.4. By End Users
   8.12. Key Representative Market Participants
   8.13. Market Presence (Intensity Map)

9. Competition Landscape
   9.1. Market Structure
   9.2. Market Share Analysis
   9.3. Competition Dashboard
   9.4. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
   9.5. Key Players
        9.5.1. Integrated DNA Technologies, Inc. 
        9.5.2. GenScript Biotech Corporation
        9.5.3. Eurofins Scientific SE
        9.5.4. Bioneer Corporation
        9.5.5. Kaneka Corporation (Eurogentec)
        9.5.6. Biolegio B.V.
        9.5.7. Eton Bioscience, Inc.
        9.5.8. IBA GmbH
        9.5.9. Quintara Biosciences
        9.5.10. LGC Biosearch Technologies
        9.5.11. Thermo Fisher Scientific, Inc.
        9.5.12. TriLink BioTechnologies, LLC
        9.5.13. TAG Copenhagen A/S
        9.5.14. PolyGen GmbH
        9.5.15. General Electric Co.  
        9.5.16. BioAutomation
        9.5.17. Biolytic Lab Performance Inc.

10. Global Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025, By Region
   10.1. Introduction
        10.1.1. Basis Point Share (BPS) Analysis By Region
        10.1.2. Y-o-Y Growth Projections By Region
   10.2. Historical Market Size Analysis 2012–2016, By Region
        10.2.1. North America
        10.2.2. Latin America
        10.2.3. Europe
        10.2.4. Asia Pacific (APAC)
        10.2.5. Middle East and Africa (MEA)
   10.3. Market Size Analysis 2017–2015, By Region
        10.3.1. North America
        10.3.2. Latin America
        10.3.3. Europe
        10.3.4. Asia Pacific (APAC)
        10.3.5. Middle East and Africa (MEA)
   10.4. Market Attractiveness Analysis By Region

11. Global Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025, By Service Type
   11.1. Introduction
        11.1.1. Basis Point Share (BPS) Analysis By Service Type
        11.1.2. Y-o-Y Growth Projections By Service Type
   11.2. Historical Market Size (US$ Mn) By Service Type, 2012-2016
        11.2.1. Universal Oligonucleotide Synthesis 
        11.2.2. Custom Oligonucleotide Synthesis
   11.3. Market Size (US$ Mn) Forecast By Service Type, 2017-2025
        11.3.1. Universal Oligonucleotide Synthesis 
        11.3.2. Custom Oligonucleotide Synthesis
   11.4. Market Attractiveness Analysis By Service Type

12. Global Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025, By Application
   12.1. Introduction
        12.1.1. Basis Point Share (BPS) Analysis By Application
        12.1.2. Y-o-Y Growth Projections By Application
   12.2. Historical Market Size (US$ Mn) By Application, 2012-2016
        12.2.1. Research & Development 
        12.2.2. Clinical & Commercial  
   12.3. Market Size (US$ Mn) Forecast By Application, 2017-2025
        12.3.1. Research & Development 
        12.3.2. Clinical & Commercial  
   12.4. Market Attractiveness Analysis By Application

13. Global Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025, By End Users
   13.1.  Introduction
        13.1.1. Basis Point Share (BPS) Analysis By End Users
        13.1.2. Y-o-Y Growth Projections By End Users
   13.2. Historical Market Size (US$ Mn) By End Users, 2012-2016
        13.2.1. Biopharmaceutical Companies
        13.2.2. Academic & Research Institutes     
        13.2.3. Contract Research Organizations
   13.3. Market Size (US$ Mn) Forecast By End Users, 2017-2025
        13.3.1. Biopharmaceutical Companies
        13.3.2. Academic & Research Institutes     
        13.3.3. Contract Research Organizations
   13.4. Market Attractiveness Analysis By End Users

14. Global Oligonucleotide Synthesis Market Analysis 2012–2016 and Forecast 2017–2025
   14.1. Market Size and Y-o-Y Growth
   14.2. Absolute $ Opportunity

15. Assumptions and Acronyms Used


List of Table

Table 1: North America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 2: North America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Service Type
Table 3: North America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application
Table 4: North America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 5: Latin America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 6: Latin America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Service Type
Table 7: Latin America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application
Table 8: Latin America Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 9: Europe Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 10: Europe Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Service Type
Table 11: Europe Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application
Table 12: Europe Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 13: Asia-Pacific Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 14: Asia-Pacific Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Service Type
Table 15: Asia-Pacific Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application
Table 16: Asia-Pacific Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 17: MEA Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 18: MEA Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Service Type
Table 19: MEA Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application
Table 20: MEA Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
MEA Oligonucleotide Synthesis Market Attractiveness Analysis, 2017–2025
Table 21: Global Oligonucleotide Synthesis Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Region 
Table 22: Global Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Service Type
Table 23: Global Oligonucleotide Synthesis Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Application 
Table 24: Global Oligonucleotide Synthesis Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025, By End Users


List of Figures

Figure 1: Oligonucleotide Synthesis Market Split By Component (2017)
Figure 2: Oligonucleotide Synthesis Market Split By Application (2017)
Figure 3: Oligonucleotide Synthesis Market Split By End Users (2017)
Figure 4: Oligonucleotide Synthesis Market Split By Region (2017)
Figure 5: North America Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 6: North America Oligonucleotide Synthesis Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 7: U.S. Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 8: U.S. Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 9: Canada Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 10: Canada Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 11: Universal Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 12: Universal Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 13: Custom Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 14: Custom Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 15: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic R&D Application Segment
Figure 16: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic R&D Application Segment
Figure 17: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Commercial R&D Segment
Figure 18: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Commercial R&D Segment
Figure 19: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Biopharmaceutical Companies End Use Segment
Figure 20: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Biopharmaceutical Companies End Use Segment
Figure 21: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic & Research Institutes End Use Segment
Figure 22: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic & Research Institutes End Use Segment
Figure 23: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Contract Research Organizations End Use Segment
Figure 24: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Contract Research Organizations End Use Segment
Figure 25: North America Oligonucleotide Synthesis Market Attractiveness Analysis, By Service Type
Figure 26: North America Oligonucleotide Synthesis Market Attractiveness Analysis, By Application 
Figure 27: North America Oligonucleotide Synthesis Market Attractiveness Analysis, By End Users  
Figure 28: North America Oligonucleotide Synthesis Market Attractiveness Analysis, By Country 
Figure 29: Oligonucleotide Synthesis Market Split By Component (2017)
Figure 30: Oligonucleotide Synthesis Market Split By Application (2017)
Figure 31: Oligonucleotide Synthesis Market Split By End Users (2017)
Figure 32: Oligonucleotide Synthesis Market Split By Region (2017)
Figure 33: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 34: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 35: Brazil Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 36: Brazil Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 37: Mexico Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 38: Mexico Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 39: Rest of Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 40: Rest of Latin America Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 41: Universal Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 42: Universal Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 43: Custom Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 44: Custom Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 45: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic R&D Application Segment
Figure 46: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic R&D Application Segment
Figure 47: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Commercial R&D Segment
Figure 48: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Commercial R&D Segment
Figure 49: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Biopharmaceutical Companies End Use Segment
Figure 50: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Biopharmaceutical Companies End Use Segment
Figure 51: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic & Research Institutes End Use Segment
Figure 52: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic & Research Institutes End Use Segment
Figure 53: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Contract Research Organizations End Use Segment
Figure 54: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 
Figure 55: Latin America Oligonucleotide Synthesis Market Attractiveness Analysis, By Service Type
Figure 56: Latin America Oligonucleotide Synthesis Market Attractiveness Analysis, By Application 
Figure 57: Latin America Oligonucleotide Synthesis Market Attractiveness Analysis, By End Users  
Figure 58: Latin America Oligonucleotide Synthesis Market Attractiveness Analysis, By Country
Figure 59: Oligonucleotide Synthesis Market Split By Service Type (2017)
Figure 60: Oligonucleotide Synthesis Market Split By Application (2017)
Figure 61: Oligonucleotide Synthesis Market Split By End Users (2017)
Figure 62: Oligonucleotide Synthesis Market Split By Region (2017)
Figure 63: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 64: Europe Oligonucleotide Synthesis Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 65: Germany Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 66: Germany Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 67: U.K. Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 68: U.K. Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 69: France Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 70: France Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 71: Italy Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 72: Italy Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 73: Spain Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 74: Spain Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 75: Russia Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 76: Russia Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 77: Rest of Europe Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 78: Rest of Europe Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 79: Universal Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 80: Universal Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 81: Custom Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 82: Custom Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 83: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic R&D Application Segment
Figure 84: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic R&D Application Segment
Figure 85: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Commercial R&D Segment
Figure 86: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Commercial R&D Segment
Figure 87: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Biopharmaceutical Companies End Use Segment
Figure 88: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Biopharmaceutical Companies End Use Segment
Figure 89: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic & Research Institutes End Use Segment
Figure 90: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic & Research Institutes End Use Segment
Figure 91: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Contract Research Organizations End Use Segment
Figure 92: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Contract Research Organizations End Use Segment
Figure 93: Europe Oligonucleotide Synthesis Market Attractiveness Analysis, By Service Type
Figure 94: Europe Oligonucleotide Synthesis Market Attractiveness Analysis, By Application 
Figure 95: Europe Oligonucleotide Synthesis Market Attractiveness Analysis, By End Users  
Figure 96: Europe Oligonucleotide Synthesis Market Attractiveness Analysis, By Country
Figure 97: Oligonucleotide Synthesis Market Split By Component (2017)
Figure 98: Oligonucleotide Synthesis Market Split By Application (2017)
Figure 99: Oligonucleotide Synthesis Market Split By End Users (2017)
Figure 100: Oligonucleotide Synthesis Market Split By Region (2017)
Figure 101: Asia-Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 102: Asia-Pacific Oligonucleotide Synthesis Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 103: China Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 104: China Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 105: Japan Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 106: Japan Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 107: India Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 108: India Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 109: ASEAN Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 110: ASEAN Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 111: Australia & New Zealand Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 112: Australia & New Zealand Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 113: Rest of Asia-Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 114: Rest of Asia-Pacific Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 115: Universal Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 116: Universal Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 117: Custom Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 118: Custom Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 119: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic R&D Application Segment
Figure 120: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic R&D Application Segment
Figure 121: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Commercial R&D Segment
Figure 122: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Commercial R&D Segment
Figure 123: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Biopharmaceutical Companies End Use Segment
Figure 124: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Biopharmaceutical Companies End Use Segment
Figure 125: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic & Research Institutes End Use Segment
Figure 126: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic & Research Institutes End Use Segment
Figure 127: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Contract Research Organizations End Use Segment
Figure 128: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Contract Research Organizations End Use Segment
Figure 129: Asia-Pacific Oligonucleotide Synthesis Market Attractiveness Analysis, By Service Type
Figure 130: Asia-Pacific Oligonucleotide Synthesis Market Attractiveness Analysis, By Application 
Figure 131: Asia-Pacific Oligonucleotide Synthesis Market Attractiveness Analysis, By End Users  
Figure 132: Asia-Pacific Oligonucleotide Synthesis Market Attractiveness Analysis, By Country
Figure 133: Oligonucleotide Synthesis Market Split By Component (2017)
Figure 134: Oligonucleotide Synthesis Market Split By Application (2017)
Figure 135: Oligonucleotide Synthesis Market Split By End Users (2017)
Figure 136: Oligonucleotide Synthesis Market Split By Region (2017)
Figure 137: MEA Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 138: MEA Oligonucleotide Synthesis Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 139: GCC Countries Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 140: GCC Countries Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 141: South Africa Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 142: South Africa Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 143: Rest of MEA Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 144: Rest of MEA Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 145: Universal Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 146: Universal Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 147: Custom Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016
Figure 148: Custom Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 149: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic R&D Application Segment
Figure 150: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic R&D Application Segment
Figure 151: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Commercial R&D Segment
Figure 152: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Commercial R&D Segment
Figure 153: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Biopharmaceutical Companies End Use Segment
Figure 154: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Biopharmaceutical Companies End Use Segment
Figure 155: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Academic & Research Institutes End Use Segment
Figure 156: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Academic & Research Institutes End Use Segment
Figure 157: Oligonucleotide Synthesis Market Size (US$ Mn) Analysis, 2012–2016 by Contract Research Organizations End Use Segment
Figure 158: Oligonucleotide Synthesis Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025 by Contract Research Organizations End Use Segment
Figure 159: MEA Oligonucleotide Synthesis Market Attractiveness Analysis, By Service Type
Figure 160: MEA Oligonucleotide Synthesis Market Attractiveness Analysis, By Application 
Figure 161: MEA Oligonucleotide Synthesis Market Attractiveness Analysis, By End Users  
Figure 162: MEA Oligonucleotide Synthesis Market Attractiveness Analysis, By Country
Figure 163: Global Oligonucleotide Synthesis Market Share Analysis (%) By Region, 2017 & 2025
Figure 164: Global Oligonucleotide Synthesis Market Y-o-Y Growth (%) By Region, 2017–2025
Figure 165: Global Oligonucleotide Synthesis Market Attractiveness Analysis By Region, 2017–2025
Figure 166: Global Oligonucleotide Synthesis Market Share Analysis (%) By Service Type, 2017 & 2025
Figure 167: Global Oligonucleotide Synthesis Market Y-o-Y Growth (%) By Service Type, 2017–2025
Figure 168: Global Oligonucleotide Synthesis Market Attractiveness Analysis By Service Type, 2017–2025
Figure 169: Global Oligonucleotide Synthesis Market Share Analysis (%) By Application, 2017 & 2025
Figure 170: Global Oligonucleotide Synthesis Market Y-o-Y Growth (%) By Application, 2016–2025
Figure 171: Global Oligonucleotide Synthesis Market Attractiveness Analysis By Drug Application, 2017–2025
Figure 172: Global Oligonucleotide Synthesis Market Share Analysis (%) By End Users, 2017 & 2025
Figure 173: Global Oligonucleotide Synthesis Market Y-o-Y Growth (%) By End Users, 2016–2025
Figure 174: Global Oligonucleotide Synthesis Market Attractiveness Analysis By End Users, 2017–2025
Figure 175: Global Oligonucleotide Synthesis Market Value Analysis and Forecast, 2016–2025 (US$ Mn)
Figure 176: Global Oligonucleotide Synthesis Market Value (US$ Mn), 2012–2016
Figure 177: Global Oligonucleotide Synthesis Market Absolute $ Opportunity (US$ Mn), 2016–2025